Display options
Cite
Hiebert NM, Seergobin KN, Vo A, et al. Dopaminergic therapy affects learning and impulsivity in Parkinson's disease. Ann Clin Transl Neurol. 2014;1(10):833-43doi: 10.1002/acn3.128.
Hiebert, N. M., Seergobin, K. N., Vo, A., Ganjavi, H., & MacDonald, P. A. (2014). Dopaminergic therapy affects learning and impulsivity in Parkinson's disease. Annals of clinical and translational neurology, 1(10), 833-43. https://doi.org/10.1002/acn3.128
Hiebert, Nole M, et al. "Dopaminergic therapy affects learning and impulsivity in Parkinson's disease." Annals of clinical and translational neurology vol. 1,10 (2014): 833-43. doi: https://doi.org/10.1002/acn3.128
Hiebert NM, Seergobin KN, Vo A, Ganjavi H, MacDonald PA. Dopaminergic therapy affects learning and impulsivity in Parkinson's disease. Ann Clin Transl Neurol. 2014 Oct;1(10):833-43. doi: 10.1002/acn3.128. Epub 2014 Oct 12. PMID: 25493274; PMCID: PMC4241810.
Copy Download .nbib Format: NLM
Share it on

Ann Clin Transl Neurol. 2014 Oct;1(10):833-43. doi: 10.1002/acn3.128. Epub 2014 Oct 12.

Dopaminergic therapy affects learning and impulsivity in Parkinson's disease.

Annals of clinical and translational neurology

Nole M Hiebert, Ken N Seergobin, Andrew Vo, Hooman Ganjavi, Penny A MacDonald

Affiliations

  1. Brain and Mind Institute, University of Western Ontario London, Ontario, Canada, N6A 5B7 ; Department of Physiology and Pharmacology, University of Western Ontario London, Ontario, Canada, N6A 5C1.
  2. Brain and Mind Institute, University of Western Ontario London, Ontario, Canada, N6A 5B7.
  3. Brain and Mind Institute, University of Western Ontario London, Ontario, Canada, N6A 5B7 ; Department of Psychology, University of Western Ontario London, Ontario, Canada, N6A 5C2.
  4. Department of Psychiatry, University of Western Ontario London, Ontario, Canada, N6A 5W9.
  5. Brain and Mind Institute, University of Western Ontario London, Ontario, Canada, N6A 5B7 ; Department of Physiology and Pharmacology, University of Western Ontario London, Ontario, Canada, N6A 5C1 ; Department of Psychology, University of Western Ontario London, Ontario, Canada, N6A 5C2 ; Department of Clinical Neurological Sciences, University of Western Ontario London, Ontario, Canada, N6A 5A5.

PMID: 25493274 PMCID: PMC4241810 DOI: 10.1002/acn3.128

Abstract

OBJECTIVE: The aim was to examine the effect of dopaminergic medication on stimulus-response learning versus performing decisions based on learning.

METHOD: To see the effect of dopaminergic therapy on stimulus-response learning and response selection, participants with Parkinson's disease (PD) were either tested on and/or off their prescribed dose of dopaminergic therapy during different testing days. Forty participants with PD and 34 healthy controls completed the experiment on consecutive days. On Day 1, participants learned to associate abstract images with spoken, "right" or "left" responses via feedback (Session 1). On Day 2, participants recalled these responses (Session 2) and indicated the location (i.e., right or left of center) of previously studied images intermixed with new images (Session 3).

RESULTS: Participants with PD off medication learned stimulus-response associations equally well compared to healthy controls. Learning was impaired by dopaminergic medication. Regardless of medication status, patients recalled the stimulus-response associations from Day 1 as well as controls. In Session 3 off medication, patients demonstrated enhanced facilitation relative to controls and patients on medication, when the stimulus location was congruent with the spoken response that was learned for the stimulus in Session 1.

INTERPRETATION: Learning in PD was comparable to that of healthy controls off medication. Learning was worsened by dopaminergic therapy in PD. We interpret greater facilitation in participants with PD off medication for congruent responses as evidence of greater impulsivity. This motor or reflexive impulsivity was normalized by medication in PD. These findings shed light on the cognitive profile of PD and have implications for dopaminergic treatment.

References

  1. Parkinsons Dis. 2011 Mar 06;2011:572743 - PubMed
  2. J Cogn Neurosci. 2010 May;22(5):848-59 - PubMed
  3. J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4 - PubMed
  4. Lancet. 1984 Dec 1;2(8414):1262-5 - PubMed
  5. Psychol Rev. 2007 Jul;114(3):632-56 - PubMed
  6. Br J Psychol. 2003 Nov;94(Pt 4):475-85 - PubMed
  7. Mov Disord. 2013 Feb;28(2):153-60 - PubMed
  8. Brain. 2012 Jun;135(Pt 6):1871-83 - PubMed
  9. J Atten Disord. 2010 Mar;13(5):497-504 - PubMed
  10. Hum Brain Mapp. 2014 Jun;35(6):2499-506 - PubMed
  11. J Cereb Blood Flow Metab. 2012 Aug;32(8):1609-17 - PubMed
  12. Nat Neurosci. 2007 Jan;10(1):126-31 - PubMed
  13. Brain. 2011 May;134(Pt 5):1447-63 - PubMed
  14. Front Syst Neurosci. 2010 Aug 12;4:null - PubMed
  15. Eur J Neurosci. 2012 Apr;35(7):1144-51 - PubMed
  16. PLoS One. 2012;7(3):e32946 - PubMed
  17. Nat Rev Neurosci. 2006 Jun;7(6):464-76 - PubMed
  18. Neuropsychologia. 2013 Nov;51(13):2562-71 - PubMed
  19. Neuropsychologia. 2000;38(5):596-612 - PubMed
  20. J Exp Psychol Learn Mem Cogn. 2003 Mar;29(2):298-306 - PubMed
  21. Eur J Neurol. 2010 Aug;17(8):1090-7 - PubMed
  22. Neuron. 2011 Feb 24;69(4):680-94 - PubMed
  23. Lancet. 1986 Oct 25;2(8513):970-1 - PubMed
  24. Neuropsychologia. 2006;44(5):774-84 - PubMed
  25. Brain. 1988 Apr;111 ( Pt 2):299-321 - PubMed
  26. Parkinsonism Relat Disord. 2011 Mar;17(3):212-4 - PubMed
  27. J Neural Transm (Vienna). 2010 Jul;117(7):855-9 - PubMed
  28. Sci Rep. 2013;3:2095 - PubMed
  29. Mov Disord. 2012 Jan;27(1):8-30 - PubMed
  30. Neuropsychology. 2011 Jan;25(1):76-85 - PubMed
  31. Psychopharmacology (Berl). 2010 Jan;207(4):645-59 - PubMed
  32. Lancet Neurol. 2009 Dec;8(12):1140-9 - PubMed
  33. Neuroimage. 2014 Nov 1;101:448-57 - PubMed
  34. Ann Clin Transl Neurol. 2014 Jun;1(6):390-400 - PubMed
  35. J Neurosci. 2011 Apr 27;31(17):6296-304 - PubMed
  36. Front Hum Neurosci. 2014 Oct 02;8:784 - PubMed
  37. Front Psychol. 2013 Sep 03;4:580 - PubMed
  38. Behav Neurosci. 1993 Feb;107(1):3-22 - PubMed
  39. J Neurol Neurosurg Psychiatry. 2007 Jun;78(6):565-70 - PubMed
  40. Neurosci Biobehav Rev. 2006;30(1):1-23 - PubMed
  41. Trends Cogn Sci. 2000 Oct 1;4(10):383-391 - PubMed
  42. PLoS One. 2013 Sep 26;8(9):e74044 - PubMed

Publication Types